ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs

ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2024-12, Vol.32 (2), p.1187-1188
Hauptverfasser: Howe, James R., Sherman, Scott K., Dillon, Joseph S.
Format: Artikel
Sprache:eng
Schlagworte:
ASO Author Reflections
FDA approval
Liver
Lymphatic system
Medicine
Medicine & Public Health
Metastasis
Neuroendocrine tumors
Oncology
Peptides
Radiation therapy
Surgery
Surgical Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1188
container_issue 2
container_start_page 1187
container_title Annals of surgical oncology
container_volume 32
creator Howe, James R.
Sherman, Scott K.
Dillon, Joseph S.
description
doi_str_mv 10.1245/s10434-024-16666-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146569512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3151306732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-32a52e681b15905a8a3b9922a24800a5c853960ae65840bcfc8508766258afbb3</originalsourceid><addsrcrecordid>eNp9kTtPwzAUhS0E4v0HGJAlFpaAX9d12KqqFKQKqtLOlpM6kCqNi50M-fe4hIfEgBdb198599oHoQtKbigTcBsoEVwkhImEyriSbg8dU4glIRXdj2ciVZIyCUfoJIQ1IXTACRyiI55KAQDqGK2HL8942DZvzuO5LSqbN6Wrwx1evFm8bMqqbDrsCjybzxe43boaz7x79TaEiOFh0didLvQybOoVHnWN83bV9pUonYxnydN4Ec7QQWGqYM-_9lO0vB8vRg_J9HnyOBpOk5yBbBLODDAbH5BRSAkYZXiWpowZJhQhBnIFcXxirAQlSJYXsUDUQEoGyhRZxk_Rde-79e69taHRmzLktqpMbV0bNKdCgkyBsohe_UHXrvV1nC5SQDmRA76jWE_l3oXgbaG3vtwY32lK9C4J3SehYxL6MwndRdHll3WbbezqR_L99RHgPRDiVf1q_W_vf2w_AHEKkhY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151306732</pqid></control><display><type>article</type><title>ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs</title><source>SpringerLink Journals</source><creator>Howe, James R. ; Sherman, Scott K. ; Dillon, Joseph S.</creator><creatorcontrib>Howe, James R. ; Sherman, Scott K. ; Dillon, Joseph S.</creatorcontrib><identifier>ISSN: 1068-9265</identifier><identifier>ISSN: 1534-4681</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-024-16666-y</identifier><identifier>PMID: 39645558</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>ASO Author Reflections ; FDA approval ; Liver ; Lymphatic system ; Medicine ; Medicine &amp; Public Health ; Metastasis ; Neuroendocrine tumors ; Oncology ; Peptides ; Radiation therapy ; Surgery ; Surgical Oncology</subject><ispartof>Annals of surgical oncology, 2024-12, Vol.32 (2), p.1187-1188</ispartof><rights>Society of Surgical Oncology 2024</rights><rights>Copyright Springer Nature B.V. Feb 2025</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-32a52e681b15905a8a3b9922a24800a5c853960ae65840bcfc8508766258afbb3</cites><orcidid>0000-0001-5312-5972</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-024-16666-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-024-16666-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39645558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Howe, James R.</creatorcontrib><creatorcontrib>Sherman, Scott K.</creatorcontrib><creatorcontrib>Dillon, Joseph S.</creatorcontrib><title>ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><subject>ASO Author Reflections</subject><subject>FDA approval</subject><subject>Liver</subject><subject>Lymphatic system</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastasis</subject><subject>Neuroendocrine tumors</subject><subject>Oncology</subject><subject>Peptides</subject><subject>Radiation therapy</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>1068-9265</issn><issn>1534-4681</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kTtPwzAUhS0E4v0HGJAlFpaAX9d12KqqFKQKqtLOlpM6kCqNi50M-fe4hIfEgBdb198599oHoQtKbigTcBsoEVwkhImEyriSbg8dU4glIRXdj2ciVZIyCUfoJIQ1IXTACRyiI55KAQDqGK2HL8942DZvzuO5LSqbN6Wrwx1evFm8bMqqbDrsCjybzxe43boaz7x79TaEiOFh0didLvQybOoVHnWN83bV9pUonYxnydN4Ec7QQWGqYM-_9lO0vB8vRg_J9HnyOBpOk5yBbBLODDAbH5BRSAkYZXiWpowZJhQhBnIFcXxirAQlSJYXsUDUQEoGyhRZxk_Rde-79e69taHRmzLktqpMbV0bNKdCgkyBsohe_UHXrvV1nC5SQDmRA76jWE_l3oXgbaG3vtwY32lK9C4J3SehYxL6MwndRdHll3WbbezqR_L99RHgPRDiVf1q_W_vf2w_AHEKkhY</recordid><startdate>20241207</startdate><enddate>20241207</enddate><creator>Howe, James R.</creator><creator>Sherman, Scott K.</creator><creator>Dillon, Joseph S.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5312-5972</orcidid></search><sort><creationdate>20241207</creationdate><title>ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs</title><author>Howe, James R. ; Sherman, Scott K. ; Dillon, Joseph S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-32a52e681b15905a8a3b9922a24800a5c853960ae65840bcfc8508766258afbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ASO Author Reflections</topic><topic>FDA approval</topic><topic>Liver</topic><topic>Lymphatic system</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastasis</topic><topic>Neuroendocrine tumors</topic><topic>Oncology</topic><topic>Peptides</topic><topic>Radiation therapy</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Howe, James R.</creatorcontrib><creatorcontrib>Sherman, Scott K.</creatorcontrib><creatorcontrib>Dillon, Joseph S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Howe, James R.</au><au>Sherman, Scott K.</au><au>Dillon, Joseph S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2024-12-07</date><risdate>2024</risdate><volume>32</volume><issue>2</issue><spage>1187</spage><epage>1188</epage><pages>1187-1188</pages><issn>1068-9265</issn><issn>1534-4681</issn><eissn>1534-4681</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39645558</pmid><doi>10.1245/s10434-024-16666-y</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-5312-5972</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2024-12, Vol.32 (2), p.1187-1188
issn 1068-9265
1534-4681
1534-4681
language eng
recordid cdi_proquest_miscellaneous_3146569512
source SpringerLink Journals
subjects ASO Author Reflections
FDA approval
Liver
Lymphatic system
Medicine
Medicine & Public Health
Metastasis
Neuroendocrine tumors
Oncology
Peptides
Radiation therapy
Surgery
Surgical Oncology
title ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A52%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ASO%20Author%20Reflections:%20The%20Utility%20of%20PRRT%20upon%20Progression%20After%20Resection%20and%20Cytoreduction%20of%20GEP-NETs&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Howe,%20James%20R.&rft.date=2024-12-07&rft.volume=32&rft.issue=2&rft.spage=1187&rft.epage=1188&rft.pages=1187-1188&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-024-16666-y&rft_dat=%3Cproquest_cross%3E3151306732%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151306732&rft_id=info:pmid/39645558&rfr_iscdi=true